Equitable Holdings Inc. Makes New $1.04 Million Investment in Astera Labs, Inc. $ALAB

Equitable Holdings Inc. bought a new stake in Astera Labs, Inc. (NASDAQ:ALAB) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 2,156 shares of the company’s stock, valued at approximately $1,041,000.

A number of other hedge funds and other institutional investors have also modified their holdings of ALAB. Keating Financial Advisory Services Inc. acquired a new position in shares of Astera Labs during the 2nd quarter valued at about $25,000. Transamerica Financial Advisors LLC acquired a new stake in Astera Labs during the second quarter worth about $35,000. Johnson Financial Group Inc. acquired a new stake in Astera Labs during the second quarter worth about $43,000. Bell Investment Advisors Inc purchased a new position in Astera Labs during the second quarter worth about $43,000. Finally, Reflection Asset Management purchased a new position in Astera Labs during the fourth quarter worth about $25,000. 60.47% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, COO Sanjay Gajendra sold 90,630 shares of Astera Labs stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the sale, the chief operating officer owned 1,119,038 shares in the company, valued at approximately $380,864,583.30. This trade represents a 7.49% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of the business’s stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $450.00, for a total value of $4,047,300.00. Following the completion of the sale, the director directly owned 4,631 shares in the company, valued at approximately $2,083,950. The trade was a 66.01% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 419,244 shares of company stock worth $163,135,169 in the last three months. 10.40% of the stock is currently owned by corporate insiders.

Astera Labs Price Performance

NASDAQ ALAB opened at $289.47 on Friday. The stock has a market capitalization of $50.22 billion, a P/E ratio of 143.30 and a beta of 3.84. The firm’s 50-day moving average is $342.38 and its two-hundred day moving average is $249.65. Astera Labs, Inc. has a 12 month low of $97.89 and a 12 month high of $499.48.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The business had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. During the same period last year, the business earned $0.44 earnings per share. The business’s revenue for the quarter was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, analysts anticipate that Astera Labs, Inc. will post 2.7 EPS for the current year.

Analyst Ratings Changes

ALAB has been the subject of several analyst reports. Needham & Company LLC increased their price target on shares of Astera Labs from $260.00 to $425.00 and gave the company a “buy” rating in a research note on Wednesday, August 5th. Citigroup reaffirmed a “buy” rating on shares of Astera Labs in a research report on Wednesday, July 29th. Stifel Nicolaus upped their price objective on Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a report on Wednesday, June 24th. Barclays increased their price objective on Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a research report on Monday, July 20th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Astera Labs in a research note on Tuesday, August 18th. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have issued a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $340.53.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.